Ever wish you could buy a rising star on discount? Indivior, the company behind a monthly shot for opioid addiction, is up nearly 200% in a year, but its stock is actually getting cheaper as profits soar. The big shift: Indivior is making more money without raising prices, thanks to a leaner business and a bigger push into long-acting treatments. If you’re looking for a stock that could keep climbing while still feeling like a deal, this might be your coffee break tip! #Business #Market #stocks